VDPP, LLC vs. GE Healthcare: 3D Viewing Patent Suit Ends in Voluntary Dismissal

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameVDPP, LLC v. GE Healthcare Technologies, Inc.
Case Number7:24-cv-00346
CourtWestern District of Texas
DurationDec 30, 2024 – Jan 5, 2026 371 days
OutcomePlaintiff Voluntary Dismissal (Without Prejudice)
Patents at Issue
Accused ProductsGE Healthcare 3D visualization and imaging products

Case Overview

The Parties

⚖️ Plaintiff

A patent holding entity asserting rights over specialized 3D display and filter spectacles technology. Operates as a non-practicing entity (NPE).

🛡️ Defendant

A global leader in medical imaging, diagnostics, and healthcare IT, with significant commercial footprint in imaging hardware and visualization solutions.

Patents at Issue

This case involved two U.S. patents relating to advanced stereoscopic 3D viewing systems — specifically, dynamically adjustable filter spectacles designed to optimize depth perception in 3D video environments.

  • US9699444B2 — “Continuous Adjustable 3Deeps Filter Spectacles for Optimized 3Deeps Stereoscopic Viewing…”
  • US9716874B2 — “Faster State Transitioning for Continuous Adjustable 3Deeps Filter Spectacles Using Multi-Layered Variable Tint Materials”
🔍

Developing 3D visualization tools?

Check if your product might infringe these or related patents before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The case terminated via voluntary dismissal without prejudice under Federal Rule of Civil Procedure 41(a)(1)(A)(i), filed by VDPP on January 2, 2026, and formally acknowledged by the court on January 5, 2026. No damages were awarded, and no injunctive relief was granted or denied on the merits. Each party was ordered to bear its own costs, expenses, and attorney fees.

Key Legal Issues

The dismissal “without prejudice” is legally significant — it preserves VDPP’s right to re-file the same claims against GE Healthcare in a future action. This procedural mechanism requires no judicial approval when exercised before the opposing party serves an answer or a motion for summary judgment, allowing VDPP to exit cleanly without triggering a fee-shifting analysis or creating adverse claim preclusion.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in 3D display and medical imaging. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View all related patents in 3D stereoscopic viewing
  • See which companies are most active in display technology IP
  • Understand claim construction patterns for filter spectacles
📊 View Patent Landscape
⚠️
High Risk Area

Dynamically adjustable 3D viewing filters

📋
2 Patents at Issue

Specific to 3D filter spectacles

Strategic Options

For early-stage dismissal or resolution

✅ Key Takeaways

For Patent Attorneys

Rule 41(a)(1)(A)(i) voluntary dismissal before defendant answers is self-effectuating and requires no court order.

Search related case law →

Without-prejudice dismissals do not bar re-filing; monitor statutes of limitations carefully.

Explore precedents →
For IP Professionals

Review VDPP’s portfolio (US9699444B2, US9716874B2) for exposure in 3D display and visualization product lines.

Start portfolio analysis →

Early IPR petitions or invalidity challenges can pressure NPE plaintiffs toward resolution before case costs escalate.

Assess patent validity →
🔒
Unlock R&D Team Recommendations
Get actionable IP strategy steps for R&D teams in 3D display and medical imaging, including FTO timing and patent landscape insights.
FTO Timing Guidance Cross-Functional IP Review Patent Landscape Insights
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. USPTO Patent Search — US9699444B2
  2. USPTO Patent Search — US9716874B2
  3. PACER Federal Court Records
  4. Western District of Texas Court Website
  5. Cornell Legal Information Institute — FRCP Rule 41

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.